about
Premature B-cell senescence as a consequence of chronic immune activation.Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults.Waning of vaccine-induced immunity to measles in kidney transplanted children.Paradoxical aging in HIV: immune senescence of B Cells is most prominent in young age.HS1,2 Ig enhancer alleles association to AIDS progression in a pediatric cohort infected with a monophyletic HIV-strainThe PEDVAC trial: preliminary data from the first therapeutic DNA vaccination in HIV-infected children.Burkitt's lymphoma mimicking EBV disease as first sign of vertical HIV infection in an adolescent.Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitorsMultidrug-resistant Acinetobacter baumannii infection in childrenTherapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC)Immunotherapy with an HIV-DNA Vaccine in Children and Adults.Early antiretroviral treatment (eART) limits viral diversity over time in a long-term HIV viral suppressed perinatally infected child.Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiencyPaediatric HIV infection in the 'omics era: defining transcriptional signatures of viral control and vaccine responses.Human breast milk: is it the best milk to prevent HIV transmission?Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children.Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort studyA systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions.How should eosinophilic cystitis be treated in patients with chronic granulomatous disease?The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children.Downfall of the current antibody correlates of influenza vaccine response in yearly vaccinated subjects: Toward qualitative rather than quantitative assays.Characterization of T and B cell repertoire diversity in patients with RAG deficiencyImmunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation.The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment.Familial hemophagocytic lymphohistiocytosis type 3 diagnosed at school age: a case report.A 2-month-old male with pyuria and persistent fever.Induction of IL21 in Peripheral T Follicular Helper Cells Is an Indicator of Influenza Vaccine Response in a Previously Vaccinated HIV-Infected Pediatric Cohort.Cellular immune profile of kidney transplant patients developing anti-HLA antibodies during childhood.Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency.Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission.Perturbation of B Cell Gene Expression Persists in HIV-Infected Children Despite Effective Antiretroviral Therapy and Predicts H1N1 Response.Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease.Inflammatory Bowel Disease in Chronic Granulomatous Disease: an emerging problem over a twenty years' experience.Role of individual's T-cell immunome in controlling HIV-1 progression.B-sides serologic markers of immunogenicity in kidney transplanted patients: report from 2012-2013 flu vaccination experience.Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.Etiology, clinical outcome, and laboratory features in children with neutropenia: analysis of 104 cases.Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference.
P50
Q27693281-9C9EB8A1-03B6-447F-9140-29199F1EC7E9Q30412019-6923029F-6C97-4E48-B275-E81FAFED062BQ33595211-C492A9C4-87C5-4F77-AE20-BF4D8CDA4928Q33657511-A9719398-9E53-405B-B954-887B1F060E7EQ33746124-D4C52EB8-07AB-4692-8384-8B93777DE26BQ33788780-1840BEEB-0DA2-4462-A791-4BCF22883722Q33864028-7FBF8941-C330-4BBA-B586-F2AF51B51CB8Q34136166-869FDCB5-B6B6-43D9-B7BD-4A3584CE305AQ34300419-1F212F58-A875-443F-9EEE-DD44EFD69403Q35060232-4A6336AC-887E-4A0F-BE95-F7A187AB1BD4Q35826642-D0E0231C-887E-4E09-A28E-D6563020F39DQ36219112-DCBEBD13-A8DC-4191-ACF8-713CA05F4231Q36266446-D7F62D6C-5D5C-41AB-AA0B-6E5650CF0D53Q36487031-754C95CD-321C-499E-B8D3-E58738687F15Q37136232-F343DE43-4015-4244-B3AF-555491319692Q37194666-FE5B5CAC-B80B-4B95-839B-59B30D7AA83AQ37626141-E82BA180-B3C4-4573-AF8F-37A8BAAC57F0Q37734244-6DF8079B-04DA-4031-82C3-DE4968C02A0DQ38036063-37C4DA25-F0B8-4FB0-937D-A8C347C591B8Q38231136-B84F71FA-307D-4A4A-A49B-845ECB49D531Q38505356-75A603EC-038E-4619-BBCC-4B28281F251BQ38611038-843E4318-B6A6-47CA-99A4-EC5C238D09A8Q38636867-0471B84F-EEEA-4A5B-9315-8DC1659448E0Q39302977-9F13B5E9-081B-4A5F-9B2F-C007AD83F157Q40143544-C449B483-EBF1-42DA-91E4-305A71CEBBB8Q40247949-38498DF0-C4E4-4ED3-9B69-204DF784546EQ40271859-80F53D5B-0B07-41D8-B595-8A5DDABC2A22Q40355338-AB3309E6-EB98-459C-9B87-03955AAF9867Q40861983-E8E484AB-B9AE-4F36-9CB0-B4D83B203675Q41070585-B19E78E5-399E-4B30-8935-FED78AFDCF92Q41102458-BB40E88D-3A50-4235-945E-45182FC7C8D7Q41684162-82D30218-4DE0-464B-B26E-0B8CB35D1820Q41759752-9A073311-037A-4C65-848A-1643936CB403Q41990756-BE18D7DE-CA37-401E-B812-F7F26BA31B1EQ42209395-CA802C54-D0A9-48C5-B7E9-8521D31BAD0DQ42211446-AD6F4D1E-6B86-4686-93AA-0F40C1E1ED6DQ42234700-97E86D5E-84EA-4908-AA81-16A9DB98E4C6Q42237059-EF18B374-6A47-4E63-BD4C-DDE02D6B1571Q42237404-E163EED6-EC12-4BBA-B0CD-DE1727406659Q42533779-9F9A1660-486A-41E6-AC7C-02DDD689A997
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paolo Palma
@ast
Paolo Palma
@en
Paolo Palma
@es
Paolo Palma
@nl
Paolo Palma
@sl
type
label
Paolo Palma
@ast
Paolo Palma
@en
Paolo Palma
@es
Paolo Palma
@nl
Paolo Palma
@sl
prefLabel
Paolo Palma
@ast
Paolo Palma
@en
Paolo Palma
@es
Paolo Palma
@nl
Paolo Palma
@sl
P106
P1153
35519174000
P21
P2798
P31
P496
0000-0002-3066-4719